Cargando…

The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients

BACKGROUND: Venous thromboembolic events (VTE) are commonly encountered in patients with lymphoma. Several risk assessments models (RAM) had attempted to identify higher risk patients with varying success. The International Prognostic Index (IPI) is a clinicopathological tool developed to help predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdel-Razeq, Hikmat, Ma’koseh, Mohammad, Abdel-Razeq, Rashid, Amarin, Rula, Abufara, Alaa, Mansour, Razan, Manasrah, Mohammad, Al-Rwashdeh, Mohammad, Bater, Rayan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195619/ https://www.ncbi.nlm.nih.gov/pubmed/34123847 http://dx.doi.org/10.3389/fonc.2021.677776

Ejemplares similares

The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Impact of Central Nervous System International Prognostic Index on the Treatment of Diffuse Large B Cell Lymphoma
por: Ma'koseh, Mohammad, et al.
Publicado: (2021)

FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
por: Ma’koseh, Mohammad, et al.
Publicado: (2021)

Trends, Patterns, and Treatment Outcomes of Cancer Among Older Patients in Jordan: A Retrospective Analysis of National Cancer Registry and Institutional Outcome Data
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2018)

Late presentation and suboptimal treatment of breast cancer among Syrian refugees: a retrospective study
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve
por: Abdel-Razeq, Hikmat
Publicado: (2010)

The Saudi clinical practice guideline for the prophylaxis of venous thromboembolism in long-distance travelers
por: Abdel-Razeq, Hikmat
Publicado: (2017)

Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Differences in clinicopathological characteristics, treatment, and survival outcomes between older and younger breast cancer patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Dealing with thrombocytopenia during anticoagulation with heparins for active venous thromboembolism: a play-it-safe practical approach
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

Prevalence and predictors of germline BRCA1 and BRCA2 mutations among young patients with breast cancer in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Patterns and predictors of thromboembolic events among patients with gastric cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

MR imaging features of intracranial primary CNS lymphoma in immune competent patients
por: Mansour, Asem, et al.
Publicado: (2014)

Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Amenorrhea, fertility preservation, and counseling among young women treated with anthracyclines and taxanes for early-stage breast cancer, a retrospective study
por: Abdel-Razeq, Hikmat N., et al.
Publicado: (2020)

Classical Hodgkin Lymphoma on the Background of Castleman Disease: A Case Report
por: Ma'koseh, Mohammad, et al.
Publicado: (2023)

Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2016)

A Durable Response of Primary Advanced Colonic Plasmacytoma Using a Combination of Surgical Resection and Adjuvant Bortezomib: A Case Report and Literature Review
por: Alfar, Rozan, et al.
Publicado: (2022)

Prolonged Neutropenia and Yellowish Discoloration of the Skin, But Not the Sclera, Following Excessive Turmeric Raw Root Ingestion
por: Abdel-Razeq, Rashid, et al.
Publicado: (2021)

Outcome of Primary Mediastinal Large B Cell Lymphoma Treated with RCHOP
por: Halahleh, Khalid, et al.
Publicado: (2023)

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2016)

Gonadotropin-releasing hormone agonists during chemotherapy for ovarian function and fertility preservation for patients with early-stage breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2019)

Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer
por: Abdel-Razeq, Hikmat
Publicado: (2019)

Expanding the search for germline pathogenic variants for breast cancer. How far should we go and how high should we jump? The missed opportunity!
por: Abdel-Razeq, Hikmat
Publicado: (2021)

Surgical options for patients with early-stage breast cancer and pathogenic germline variants: an oncologist perspectives
por: Abdel-Razeq, Hikmat
Publicado: (2023)

Cement pulmonary embolism as a complication of percutaneous vertebroplasty in cancer patients
por: Mansour, Asem, et al.
Publicado: (2018)

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Breast Cancer Care in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2020)

Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income Country
por: Al-Tabba', Amal, et al.
Publicado: (2020)

Pathogenic germline variants in patients with breast cancer: conversations across generations, practices and patients’ attitude
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2023)

Thrombosis and Anticoagulant Therapy Among Pediatric Cancer Patients: Real-Life Data
por: Hashem, Hasan, et al.
Publicado: (2021)

Complete and Durable Response to Tamoxifen and Ovarian Ablation in the Treatment of Metastatic Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Current neoadjuvant treatment options for HER2-positive breast cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
por: Edaily, Sarah, et al.
Publicado: (2022)

Treatment options for patients with hormone receptor-positive, HER2-negative advanced-stage breast cancer: maintaining cyclin-dependent kinase 4/6 inhibitors beyond progression
por: Horani, Malek, et al.
Publicado: (2023)

Inferior vena cava filters in cancer patients: to filter or not to filter
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_prk66bu1at4h5eq0kf6g18q3i5